VA Announces Clinical Trial Using Ecstasy to Aid Veterans with Severe Mental Health Disorders

VA announces clinical trial using Ecstasy to aid veterans with severe mental health disorders

FDA grants therapy designation to several psychedelic substances, including MDMA, psilocybin and LSD, allowing for expedited review of these drugs.

Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial

It’s been an incredibly busy few weeks since our last Bulletin, with Psychedelic Alpha on the road in the U.S. (for APA’s annual meeting and a visit to Stanford and the valley), The Real Mental Health Summit in London, and now the Interdisciplinary Conference on Psychedelic Research in Haarlem, the Netherlands. We have published a wealth of content since our last Bulletin… Source